Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.00    2.50 (5.88%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £86.34m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Production Update

23 Apr 2014 07:00

RNS Number : 2721F
Iofina PLC
23 April 2014
 

 

 

23 April 2014

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

 

Production Update

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, provides the market with an update on forecast production at its existing IOsorb™ production sites.

 

The Group has recently gained insight into its principal Operator's planned fracking scheduling for the next three months. The Operator's schedule is expected to significantly reduce the brine supply and as a consequence, plant runtime for IOsorb™ plants IO#3, IO#4, IO#5 and IO#6 will be affected. Current indications are that the fracking program will continue through the end of 2014 at levels similar to those projected for the next three months. Whilst this has a significant impact on current brine supply, the increased drilling is a positive indication of the operator's view to continue expansion, which should bode well for the longer term prospects of the Company. Plants IO#1 and IO#2 remain profitable are unaffected by fracking schedules and continue to produce iodine as planned.

The Group has reviewed its production forecasts in light of the above and on the basis that the principal Operators fracking schedule for the three months continues for the remainder of the year, anticipates that production for the current calendar year will be circa 400 metric tonnes of crystallized iodine. Whilst this is a significant increase over 2013 production, it is materially below current market expectations.

In light of this development, steps are being taken to minimise expenses both at corporate and operational level, including curtailing production at IO#5, which is powered by mobile power generation until hard power is installed from the local utility expected in the next 90 days, reduction in staffing to reflect plant down time, reducing production payments to the operator and reviewing mobile plant deployment. Such measures are being undertaken to conserve the Group's cash position which was $2.3M at the end of March. The Company is also working on ways to re-route additional water from the Operator.

Production for the first quarter was 47 metric tonnes of crystallized iodine and was affected by more fracking than was originally anticipated and extreme winter weather experienced in the location of the plants. Iofina Chemical has enjoyed a good start to the year and has performed ahead of management's expectations.

For further information, please contact:

George Lantz, CEO

Iofina

Tel: +44 (0)20 3006 3135

www.iofina.com

 

John Prior/Rupert Krefting/Huw Jeremy

Numis Securities

Tel: +44 (0)20 7260 1000

 

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

 

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, Montana and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGZDGZZGDZZ
Date   Source Headline
9th May 20237:00 amRNSNotice of AGM
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20234:45 pmRNSHolding(s) in Company
28th Apr 20237:00 amRNSGrant of Share Options
25th Apr 20237:00 amRNS2022 FULL YEAR RESULTS
12th Apr 20237:00 amRNSProduction Update
20th Feb 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Update
9th Jan 20237:00 amRNSMarket Update
28th Dec 20222:34 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSIofina Chemical Awarded ISO Certification
21st Nov 20227:00 amRNSChange of Adviser
28th Oct 20227:00 amRNSFinalised Terms for IO9 & Q3 Production Update
26th Sep 202211:06 amRNSSecond Price Monitoring Extn
26th Sep 202211:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSInterim Results
8th Jul 20227:00 amRNSAdditional Loan Facilities and H1 Update
5th Jul 20228:54 amRNSHolding(s) in Company
22nd Jun 20222:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSAppointment of Chrystal Capital Partners LLP
27th May 20227:00 amRNSNotice of AGM
26th May 20224:15 pmRNSHolding(s) in Company
26th May 20222:15 pmRNSHolding(s) in Company
24th May 20226:15 pmRNSHolding(s) in Company
20th May 20227:10 amRNSInvestor Presentation
18th May 20227:00 amRNSHolding(s) in Company
9th May 20227:00 amRNSFinal Results
5th May 20227:00 amRNSHolding(s) in Company
28th Apr 20228:38 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSQ1 2022 and IO#9 Update
8th Apr 20221:07 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector/PDMR Shareholding
11th Mar 20227:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSGrant of Share Options
8th Mar 20228:51 amRNSHolding(s) in Company
17th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSQ4 2021 Update
10th Jan 20227:00 amRNSHolding(s) in Company
10th Jan 20227:00 amRNSHolding(s) in Company
10th Jan 20227:00 amRNSHolding(s) in Company
29th Dec 20217:00 amRNSBusiness Update
20th Oct 202112:44 pmRNSHolding(s) in Company
15th Oct 20217:00 amRNSQ3 2021 Update
12th Oct 20218:47 amRNSHolding(s) in Company
24th Sep 20217:00 amRNSInterim Results
23rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.